Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: Randomised controlled trial

C. E. Bucknall*, G. Miller, S. M. Lloyd, J. Cleland, S. McCluskey, M. Cotton, R. D. Stevenson, P. Cotton, A. McConnachie

*Corresponding author for this work

Research output: Contribution to journalArticle

145 Citations (Scopus)
1 Downloads (Pure)

Abstract

Objective: To determine whether supported self management in chronic obstructive pulmonary disease (COPD) can reduce hospital readmissions in the United Kingdom. Design: Randomised controlled trial. Setting: Community based intervention in the west of Scotland. Participants: Patients admitted to hospital with acute exacerbation of COPD. Intervention: Participants in the intervention group were trained to detect and treat exacerbations promptly, with ongoing support for 12 months. Main outcome measures: The primary outcome was hospital readmissions and deaths due to COPD assessed by record linkage of Scottish Morbidity Records; health related quality of life measures were secondary outcomes. Results: 464 patients were randomised, stratified by age, sex, per cent predicted forced expiratory volume in 1 second, recent pulmonary rehabilitation attendance, smoking status, deprivation category of area of residence, and previous COPD admissions. No difference was found in COPD admissions or death (111/232 (48%) v 108/232 (47%); hazard ratio 1.05, 95% confidence interval 0.80 to 1.38). Return of health related quality of life questionnaires was poor (n=265; 57%), so that no useful conclusions could be made from these data. Pre-planned subgroup analysis showed no differential benefit in the primary outcome relating to disease severity or demographic variables. In an exploratory analysis, 42% (75/150) of patients in the intervention group were classified as successful self managers at study exit, from review of appropriateness of use of self management therapy. Predictors of successful self management on stepwise regression were younger age (P=0.012) and living with others (P=0.010). COPD readmissions/deaths were reduced in successful self managers compared with unsuccessful self managers (20/75 (27%) v 51/105 (49%); hazard ratio 0.44, 0.25 to 0.76; P=0.003). Conclusion: Supported self management had no effect on time to first readmission or death with COPD. Exploratory subgroup analysis identified a minority of participants who learnt to self manage; this group had a significantly reduced risk of COPD readmission, were younger, and were more likely to be living with others. Trial registration: Clinical trials NCT 00706303.

Original languageEnglish
Article numbere1060
Number of pages13
JournalBMJ (Online)
Volume344
Issue number7849
DOIs
Publication statusPublished - 24 Mar 2012

Fingerprint

Self Care
Chronic Obstructive Pulmonary Disease
Randomized Controlled Trials
Patient Readmission
Regional Health Planning
Quality of Life
Forced Expiratory Volume
Scotland
Rehabilitation
Smoking
Demography
Outcome Assessment (Health Care)
Clinical Trials
Confidence Intervals
Morbidity
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bucknall, C. E., Miller, G., Lloyd, S. M., Cleland, J., McCluskey, S., Cotton, M., ... McConnachie, A. (2012). Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: Randomised controlled trial. BMJ (Online), 344(7849), [e1060]. https://doi.org/10.1136/bmj.e1060

Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD : Randomised controlled trial. / Bucknall, C. E.; Miller, G.; Lloyd, S. M.; Cleland, J.; McCluskey, S.; Cotton, M.; Stevenson, R. D.; Cotton, P.; McConnachie, A.

In: BMJ (Online), Vol. 344, No. 7849, e1060, 24.03.2012.

Research output: Contribution to journalArticle

Bucknall, CE, Miller, G, Lloyd, SM, Cleland, J, McCluskey, S, Cotton, M, Stevenson, RD, Cotton, P & McConnachie, A 2012, 'Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: Randomised controlled trial', BMJ (Online), vol. 344, no. 7849, e1060. https://doi.org/10.1136/bmj.e1060
Bucknall, C. E. ; Miller, G. ; Lloyd, S. M. ; Cleland, J. ; McCluskey, S. ; Cotton, M. ; Stevenson, R. D. ; Cotton, P. ; McConnachie, A. / Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD : Randomised controlled trial. In: BMJ (Online). 2012 ; Vol. 344, No. 7849.
@article{b3010ed40b144a9eb96c3dd56d4667bf,
title = "Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: Randomised controlled trial",
abstract = "Objective: To determine whether supported self management in chronic obstructive pulmonary disease (COPD) can reduce hospital readmissions in the United Kingdom. Design: Randomised controlled trial. Setting: Community based intervention in the west of Scotland. Participants: Patients admitted to hospital with acute exacerbation of COPD. Intervention: Participants in the intervention group were trained to detect and treat exacerbations promptly, with ongoing support for 12 months. Main outcome measures: The primary outcome was hospital readmissions and deaths due to COPD assessed by record linkage of Scottish Morbidity Records; health related quality of life measures were secondary outcomes. Results: 464 patients were randomised, stratified by age, sex, per cent predicted forced expiratory volume in 1 second, recent pulmonary rehabilitation attendance, smoking status, deprivation category of area of residence, and previous COPD admissions. No difference was found in COPD admissions or death (111/232 (48{\%}) v 108/232 (47{\%}); hazard ratio 1.05, 95{\%} confidence interval 0.80 to 1.38). Return of health related quality of life questionnaires was poor (n=265; 57{\%}), so that no useful conclusions could be made from these data. Pre-planned subgroup analysis showed no differential benefit in the primary outcome relating to disease severity or demographic variables. In an exploratory analysis, 42{\%} (75/150) of patients in the intervention group were classified as successful self managers at study exit, from review of appropriateness of use of self management therapy. Predictors of successful self management on stepwise regression were younger age (P=0.012) and living with others (P=0.010). COPD readmissions/deaths were reduced in successful self managers compared with unsuccessful self managers (20/75 (27{\%}) v 51/105 (49{\%}); hazard ratio 0.44, 0.25 to 0.76; P=0.003). Conclusion: Supported self management had no effect on time to first readmission or death with COPD. Exploratory subgroup analysis identified a minority of participants who learnt to self manage; this group had a significantly reduced risk of COPD readmission, were younger, and were more likely to be living with others. Trial registration: Clinical trials NCT 00706303.",
author = "Bucknall, {C. E.} and G. Miller and Lloyd, {S. M.} and J. Cleland and S. McCluskey and M. Cotton and Stevenson, {R. D.} and P. Cotton and A. McConnachie",
year = "2012",
month = "3",
day = "24",
doi = "10.1136/bmj.e1060",
language = "English",
volume = "344",
journal = "BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "7849",

}

TY - JOUR

T1 - Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD

T2 - Randomised controlled trial

AU - Bucknall, C. E.

AU - Miller, G.

AU - Lloyd, S. M.

AU - Cleland, J.

AU - McCluskey, S.

AU - Cotton, M.

AU - Stevenson, R. D.

AU - Cotton, P.

AU - McConnachie, A.

PY - 2012/3/24

Y1 - 2012/3/24

N2 - Objective: To determine whether supported self management in chronic obstructive pulmonary disease (COPD) can reduce hospital readmissions in the United Kingdom. Design: Randomised controlled trial. Setting: Community based intervention in the west of Scotland. Participants: Patients admitted to hospital with acute exacerbation of COPD. Intervention: Participants in the intervention group were trained to detect and treat exacerbations promptly, with ongoing support for 12 months. Main outcome measures: The primary outcome was hospital readmissions and deaths due to COPD assessed by record linkage of Scottish Morbidity Records; health related quality of life measures were secondary outcomes. Results: 464 patients were randomised, stratified by age, sex, per cent predicted forced expiratory volume in 1 second, recent pulmonary rehabilitation attendance, smoking status, deprivation category of area of residence, and previous COPD admissions. No difference was found in COPD admissions or death (111/232 (48%) v 108/232 (47%); hazard ratio 1.05, 95% confidence interval 0.80 to 1.38). Return of health related quality of life questionnaires was poor (n=265; 57%), so that no useful conclusions could be made from these data. Pre-planned subgroup analysis showed no differential benefit in the primary outcome relating to disease severity or demographic variables. In an exploratory analysis, 42% (75/150) of patients in the intervention group were classified as successful self managers at study exit, from review of appropriateness of use of self management therapy. Predictors of successful self management on stepwise regression were younger age (P=0.012) and living with others (P=0.010). COPD readmissions/deaths were reduced in successful self managers compared with unsuccessful self managers (20/75 (27%) v 51/105 (49%); hazard ratio 0.44, 0.25 to 0.76; P=0.003). Conclusion: Supported self management had no effect on time to first readmission or death with COPD. Exploratory subgroup analysis identified a minority of participants who learnt to self manage; this group had a significantly reduced risk of COPD readmission, were younger, and were more likely to be living with others. Trial registration: Clinical trials NCT 00706303.

AB - Objective: To determine whether supported self management in chronic obstructive pulmonary disease (COPD) can reduce hospital readmissions in the United Kingdom. Design: Randomised controlled trial. Setting: Community based intervention in the west of Scotland. Participants: Patients admitted to hospital with acute exacerbation of COPD. Intervention: Participants in the intervention group were trained to detect and treat exacerbations promptly, with ongoing support for 12 months. Main outcome measures: The primary outcome was hospital readmissions and deaths due to COPD assessed by record linkage of Scottish Morbidity Records; health related quality of life measures were secondary outcomes. Results: 464 patients were randomised, stratified by age, sex, per cent predicted forced expiratory volume in 1 second, recent pulmonary rehabilitation attendance, smoking status, deprivation category of area of residence, and previous COPD admissions. No difference was found in COPD admissions or death (111/232 (48%) v 108/232 (47%); hazard ratio 1.05, 95% confidence interval 0.80 to 1.38). Return of health related quality of life questionnaires was poor (n=265; 57%), so that no useful conclusions could be made from these data. Pre-planned subgroup analysis showed no differential benefit in the primary outcome relating to disease severity or demographic variables. In an exploratory analysis, 42% (75/150) of patients in the intervention group were classified as successful self managers at study exit, from review of appropriateness of use of self management therapy. Predictors of successful self management on stepwise regression were younger age (P=0.012) and living with others (P=0.010). COPD readmissions/deaths were reduced in successful self managers compared with unsuccessful self managers (20/75 (27%) v 51/105 (49%); hazard ratio 0.44, 0.25 to 0.76; P=0.003). Conclusion: Supported self management had no effect on time to first readmission or death with COPD. Exploratory subgroup analysis identified a minority of participants who learnt to self manage; this group had a significantly reduced risk of COPD readmission, were younger, and were more likely to be living with others. Trial registration: Clinical trials NCT 00706303.

UR - http://www.scopus.com/inward/record.url?scp=84858802053&partnerID=8YFLogxK

U2 - 10.1136/bmj.e1060

DO - 10.1136/bmj.e1060

M3 - Article

C2 - 22395923

AN - SCOPUS:84858802053

VL - 344

JO - BMJ

JF - BMJ

SN - 0959-8146

IS - 7849

M1 - e1060

ER -